Prot# PCYC-0211: Randomized Phase III Trial of Xcytrin® (Motexafin Gadolinium) Injection for the Treatment of Brain Metastases in Patients with Non-Small Cell Lung Cancer Undergoing Whole Brain Radiation Therapy (WBRT)

Project: Research project

Project Details

StatusFinished
Effective start/end date2/5/03 → 8/22/07

Funding

  • PPD Development (PCYC-0211)
  • Pharmacyclics, Inc. (PCYC-0211)